Author:
Pérez-Barbosa L.,Esquivel-Valerio J. A.,Arana-Guajardo A. C.,Vega-Morales D.,Riega-Torres J.,Garza-Elizondo M. A.
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference32 articles.
1. Carmona L, Hernández-García C, Vadillo C, Pato E, Balsa A, González-Alvaro I et al (2003) Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 30:1436–1439
2. Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, BIOBADASER Group (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48:2122–2127
3. Carmona L, Gómez-Reino JJ, Rodíguez-Velarde V, Montero D, Pascual-Gómez E, Mola EM et al (2005) Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 52:1766–1772
4. Migita K, Umeno T, Miyagawa K, Izumi Y, Sasaki E, Kakugawa T et al (2012) on the other hand it is necessary to identify patients who do not require prophylaxis to prevent adverse events of anti-TB drugs. Rheumatol Int 32:1375–1377
5. Haroon M, Martin U, Devlin J (2012) High incidence of intolerance to tuberculosis chemoprophylaxis. Rheumatol Int 32:33–37
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献